Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000032836 | SCV001726734 | benign | 5-Oxoprolinase deficiency | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000032836 | SCV002802994 | likely benign | 5-Oxoprolinase deficiency | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003914892 | SCV004731951 | likely benign | OPLAH-related disorder | 2020-11-30 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
OMIM | RCV000032836 | SCV000056605 | pathogenic | 5-Oxoprolinase deficiency | 2013-01-01 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000032836 | SCV001142394 | benign | 5-Oxoprolinase deficiency | 2020-01-06 | no assertion criteria provided | curation | NM_017570.3:c.3265G>A in the OPLAH gene has an allele frequency of 0.024 in Latino subpopulation in the gnomAD database, including 13 homozygous occurrences. It has been detected in heterozygous state in one individual with 5-oxoprolinuria (PMID: 23430506). Taken together, we interprete this variant as Benign/Likely benign variant. ACMG/AMP criteria applied: BS1, BS2, PP4. |